Genetic Testing Market by Product, End-user, Application, and Geography - Forecast and Analysis 2020-2024

Genetic Testing Market by Product, End-user, Application, and Geography - Forecast and Analysis 2020-2024

Global Genetic Testing Market: About this market

Technavio’s genetic testing market analysis considers sales from both equipment and consumable products. Our study also finds the sales of genetic testing in Asia, Europe, North America, and ROW. In 2019, the equipment segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing workload for performing high-throughput tests in clinical diagnostic facilities will play a significant role in the equipment segment to maintain its market position. Also, our global genetic testing market report looks at factors such as rising prevalence of genetic diseases and disorders, rising approval of advanced genetic testing products, and increasing affordability due to reduction in cost of genetic testing. However, varying regulations on genetic testing and research globally, issues related to product recalls, and lack of trained genetic professionals may hamper the growth of the genetic testing industry over the forecast period.

Global Genetic Testing Market: Overview

Rising approval of advanced genetic testing products

Commercial applications of genetic screening in human health management and the advent of whole genome sequencing have allowed vendors to offer a variety of innovative products in the global genetic testing market. The use of advanced technologies such as pharmacogenomics and companion diagnostics has helped vendors in assuring the safety of their products. Furthermore, the deployment of rapid and simplified technologies in genetic testing offers several benefits including the reduction in turnaround time, optimum resource use, and accuracy in genetic diagnosis. Thus, the rising approval of advanced genetic testing products will lead to the expansion of the global genetic testing market at a CAGR of over 12% during the forecast period.

Growing adoption of pharmacogenetic testing in reducing adverse drug events

The growing approval of new drug molecules and the rising demand for targeted therapies and personalized medicines have increased the adoption of pharmacogenomic testing by pharmaceutical companies. Pharmacogenomic testing combines the principles of pharmacology and genomics to study the response of an individual to any specific drug. The study of drug-specific responses allows pharmaceutical companies to prevent adverse drug incidence and ensure drug safety and performance during pre and post commercial stages. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global genetic testing market during the forecast period 2020-2024, click here.

Competitive Landscape

With the presence of several major players, the global genetic testing market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genetic testing manufacturers, that include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.

Also, the genetic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global healthcare market
      • Table Segments of global healthcare market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
    • Value Chain Analysis
  • Market sizing
    • Market definition
      • Table Vendor offerings
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2019
      • Table Market size 2019
    • Market size and forecast 2019-2024
      • Table Global market: Size and forecast 2019-2024 ($ millions)
      • Table Global market: Year-over-year growth 2020-2024 (%)
    • Market Outlook
  • Five forces analysis
    • Table Five forces analysis 2019
    • Table Five forces analysis 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market segmentation by product
    • Table Product - Market share 2019-2024 (%)
    • Comparison by product
      • Table Comparison by product
    • Equipment - Market size and forecast 2019-2024
      • Table Equipment - Market size and forecast 2019-2024 ($ millions)
      • Table Equipment - Year-over-year growth 2020-2024 (%)
    • Consumables - Market size and forecast 2019-2024
      • Table Consumables - Market size and forecast 2019-2024 ($ millions)
      • Table Consumables - Year-over-year growth 2020-2024 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Market segmentation by end-user
    • Table Global genetic testing market segmentation by end-user 2019 (% share)
    • Clinical diagnostics laboratories
    • Hospitals
    • Biopharmaceutical companies and research centers
  • Market segmentation by application
    • Table Global genetic testing market segmentation by application 2019 (% share)
    • Predictive and diagnostic testing
    • Prenatal, newborn and preimplantation testing
    • Pharmacogenomic testing
    • Forensic, relationship and ancestry testing
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2019-2024
      • Table North America - Market size and forecast 2019-2024 ($ millions)
      • Table North America - Year-over-year growth 2020-2024 (%)
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ millions)
      • Table Europe - Year-over-year growth 2020-2024 (%)
    • Asia - Market size and forecast 2019-2024
      • Table Asia - Market size and forecast 2019-2024 ($ millions)
      • Table Asia - Year-over-year growth 2020-2024 (%)
    • ROW - Market size and forecast 2019-2024
      • Table ROW - Market size and forecast 2019-2024 ($ millions)
      • Table ROW - Year-over-year growth 2020-2024 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Customer landscape
    • Table Customer landscape
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • Advancements in next-generation sequencing
    • Growing adoption of direct-to-consumer genetic tests in early disease diagnosis
    • Growing adoption of pharmacogenetic testing in reducing adverse drug events
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Abbott Laboratories
      • Table Abbott Laboratories - Vendor overview
      • Table Abbott Laboratories - Product segments
      • Table Abbott Laboratories - Organizational developments
      • Table Abbott Laboratories - Geographic focus
      • Table Abbott Laboratories - Segment focus
      • Table Abbott Laboratories - Key offerings
    • Agilent Technologies Inc.
      • Table Agilent Technologies Inc. - Vendor overview
      • Table Agilent Technologies Inc. - Business segments
      • Table Agilent Technologies Inc. - Organizational developments
      • Table Agilent Technologies Inc. - Geographic focus
      • Table Agilent Technologies Inc. - Segment focus
      • Table Agilent Technologies Inc. - Key offerings
    • bioMérieux SA
      • Table bioMérieux SA - Vendor overview
      • Table bioMérieux SA - Business segments
      • Table bioMérieux SA - Organizational developments
      • Table bioMérieux SA - Geographic focus
      • Table bioMérieux SA - Key offerings
    • Bio-Rad Laboratories Inc.
      • Table Bio-Rad Laboratories Inc. - Vendor overview
      • Table Bio-Rad Laboratories Inc. - Business segments
      • Table Bio-Rad Laboratories Inc. - Organizational developments
      • Table Bio-Rad Laboratories Inc. - Geographic focus
      • Table Bio-Rad Laboratories Inc. - Segment focus
      • Table Bio-Rad Laboratories Inc. - Key offerings
    • F. Hoffmann-La Roche Ltd.
      • Table F. Hoffmann-La Roche Ltd. - Vendor overview
      • Table F. Hoffmann-La Roche Ltd. - Business segments
      • Table F. Hoffmann-La Roche Ltd. - Organizational developments
      • Table F. Hoffmann-La Roche Ltd. - Geographic focus
      • Table F. Hoffmann-La Roche Ltd. - Segment focus
      • Table F. Hoffmann-La Roche Ltd. - Key offerings
    • Illumina Inc.
      • Table Illumina Inc. - Vendor overview
      • Table Illumina Inc. - Business segments
      • Table Illumina Inc. - Organizational developments
      • Table Illumina Inc. - Geographic focus
      • Table Illumina Inc. - Segment focus
      • Table Illumina Inc. - Key offerings
    • Myriad Genetics Inc.
      • Table Myriad Genetics Inc. - Vendor overview
      • Table Myriad Genetics Inc. - Business segments
      • Table Myriad Genetics Inc. - Organizational developments
      • Table Myriad Genetics Inc. - Segment focus
      • Table Myriad Genetics Inc. - Key offerings
    • QIAGEN NV
      • Table QIAGEN NV - Vendor overview
      • Table QIAGEN NV - Product segments
      • Table QIAGEN NV - Organizational developments
      • Table QIAGEN NV - Geographic focus
      • Table QIAGEN NV - Segment focus
      • Table QIAGEN NV - Key offerings
    • Quest Diagnostics Inc.
      • Table Quest Diagnostics Inc. - Vendor overview
      • Table Quest Diagnostics Inc. - Business segments
      • Table Quest Diagnostics Inc. - Organizational developments
      • Table Quest Diagnostics Inc. - Segment focus
      • Table Quest Diagnostics Inc. - Key offerings
    • Thermo Fisher Scientific Inc.
      • Table Thermo Fisher Scientific Inc. - Vendor overview
      • Table Thermo Fisher Scientific Inc. - Business segments
      • Table Thermo Fisher Scientific Inc. - Organizational developments
      • Table Thermo Fisher Scientific Inc. - Geographic focus
      • Table Thermo Fisher Scientific Inc. - Segment focus
      • Table Thermo Fisher Scientific Inc. - Key offerings
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook